 | • レポートコード：QYR2104Z4414 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、膵臓ベータ細胞保護のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞ベース、遺伝子治療、RNAベース治療、モノクローナル抗体（MAb）、フィトセラピー）、用途別市場規模（病院、医学研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・膵臓ベータ細胞保護の市場動向 ・企業の競争状況、市場シェア ・膵臓ベータ細胞保護の種類別市場規模（幹細胞ベース、遺伝子治療、RNAベース治療、モノクローナル抗体（MAb）、フィトセラピー） ・膵臓ベータ細胞保護の用途別市場規模（病院、医学研究所、その他） ・膵臓ベータ細胞保護の北米市場規模2016-2027（アメリカ、カナダ） ・膵臓ベータ細胞保護のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・膵臓ベータ細胞保護のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膵臓ベータ細胞保護の中南米市場規模2016-2027（メキシコ、ブラジル） ・膵臓ベータ細胞保護の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ViaCyte、PharmaCyte Biotech、Boehringer Ingelheim、GalaxoSmithKline、Beta-Cell NV、Novartis、Janssen Research & Development、Pfizer Inc、BioLineRx、Genentech、Novo Nordisk、Sanofi、Osiris Therapeutics、Beta-O2 Technologies Ltd、Transition Therapeutics） ・結論 |
Beta Cells. Beta cells are unique cells in the pancreas that produce, store and release the hormone insulin.
Market Analysis and Insights: Global Pancreatic Beta-Cell Protection Market
The global Pancreatic Beta-Cell Protection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Beta-Cell Protection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Beta-Cell Protection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Beta-Cell Protection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Beta-Cell Protection market.
Global Pancreatic Beta-Cell Protection Scope and Market Size
Pancreatic Beta-Cell Protection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Beta-Cell Protection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Stem Cell Based
Gene Therapies
RNA Based Therapies
Monoclonal Antibodies (MAbs)
Phytotherapy
Segment by Application
Hospital
Medical Research Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ViaCyte
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx
GalaxoSmithKline
Beta-Cell NV
Sanofi
Osiris Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2016-2027)
2.2 Pancreatic Beta-Cell Protection Growth Trends by Regions
2.2.1 Pancreatic Beta-Cell Protection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Beta-Cell Protection Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Beta-Cell Protection Industry Dynamic
2.3.1 Pancreatic Beta-Cell Protection Market Trends
2.3.2 Pancreatic Beta-Cell Protection Market Drivers
2.3.3 Pancreatic Beta-Cell Protection Market Challenges
2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2020
3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served
3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Market Size (2016-2027)
6.2 North America Pancreatic Beta-Cell Protection Market Size by Type
6.2.1 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
6.3 North America Pancreatic Beta-Cell Protection Market Size by Application
6.3.1 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
6.4 North America Pancreatic Beta-Cell Protection Market Size by Country
6.4.1 North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Market Size (2016-2027)
7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type
7.2.1 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application
7.3.1 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country
7.4.1 Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type
8.2.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application
8.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region
8.4.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2016-2027)
9.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type
9.2.1 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application
9.3.1 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country
9.4.1 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type
10.2.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application
10.3.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country
10.4.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.1.5 ViaCyte Recent Development
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Details
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.2.5 PharmaCyte Biotech Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Details
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.4.5 GalaxoSmithKline Recent Development
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Details
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.5.5 Beta-Cell NV Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Details
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.7.5 Janssen Research & Development Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.8.5 Pfizer Inc Recent Development
11.9 BioLineRx
11.9.1 BioLineRx Company Details
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.9.5 BioLineRx Recent Development
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.10.5 Genentech Recent Development
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Details
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.11.5 Novo Nordisk Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Details
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.13.5 Osiris Therapeutics Recent Development
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Details
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.14.5 Beta-O2 Technologies Ltd Recent Development
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Details
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.15.5 Transition Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stem Cell Based
Table 3. Key Players of Gene Therapies
Table 4. Key Players of RNA Based Therapies
Table 5. Key Players of Monoclonal Antibodies (MAbs)
Table 6. Key Players of Phytotherapy
Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pancreatic Beta-Cell Protection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pancreatic Beta-Cell Protection Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pancreatic Beta-Cell Protection Market Share by Regions (2016-2021)
Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027)
Table 13. Pancreatic Beta-Cell Protection Market Trends
Table 14. Pancreatic Beta-Cell Protection Market Drivers
Table 15. Pancreatic Beta-Cell Protection Market Challenges
Table 16. Pancreatic Beta-Cell Protection Market Restraints
Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pancreatic Beta-Cell Protection Market Share by Players (2016-2021)
Table 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020)
Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021)
Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pancreatic Beta-Cell Protection Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2016-2021)
Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 64. ViaCyte Company Details
Table 65. ViaCyte Business Overview
Table 66. ViaCyte Pancreatic Beta-Cell Protection Product
Table 67. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 68. ViaCyte Recent Development
Table 69. PharmaCyte Biotech Company Details
Table 70. PharmaCyte Biotech Business Overview
Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
Table 72. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 73. PharmaCyte Biotech Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
Table 77. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. GalaxoSmithKline Company Details
Table 80. GalaxoSmithKline Business Overview
Table 81. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
Table 82. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 83. GalaxoSmithKline Recent Development
Table 84. Beta-Cell NV Company Details
Table 85. Beta-Cell NV Business Overview
Table 86. Beta-Cell NV Pancreatic Beta-Cell Protection Product
Table 87. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 88. Beta-Cell NV Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Pancreatic Beta-Cell Protection Product
Table 92. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Janssen Research & Development Company Details
Table 95. Janssen Research & Development Business Overview
Table 96. Janssen Research & Development Pancreatic Beta-Cell Protection Product
Table 97. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 98. Janssen Research & Development Recent Development
Table 99. Pfizer Inc Company Details
Table 100. Pfizer Inc Business Overview
Table 101. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 102. Pfizer Inc Recent Development
Table 103. BioLineRx Company Details
Table 104. BioLineRx Business Overview
Table 105. BioLineRx Pancreatic Beta-Cell Protection Product
Table 106. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 107. BioLineRx Recent Development
Table 108. Genentech Company Details
Table 109. Genentech Business Overview
Table 110. Genentech Pancreatic Beta-Cell Protection Product
Table 111. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 112. Genentech Recent Development
Table 113. Novo Nordisk Company Details
Table 114. Novo Nordisk Business Overview
Table 115. Novo Nordisk Pancreatic Beta-Cell Protection Product
Table 116. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 117. Novo Nordisk Recent Development
Table 118. Sanofi Company Details
Table 119. Sanofi Business Overview
Table 120. Sanofi Pancreatic Beta-Cell Protection Product
Table 121. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 122. Sanofi Recent Development
Table 123. Osiris Therapeutics Company Details
Table 124. Osiris Therapeutics Business Overview
Table 125. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
Table 126. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 127. Osiris Therapeutics Recent Development
Table 128. Beta-O2 Technologies Ltd Company Details
Table 129. Beta-O2 Technologies Ltd Business Overview
Table 130. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
Table 131. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 132. Beta-O2 Technologies Ltd Recent Development
Table 133. Transition Therapeutics Company Details
Table 134. Transition Therapeutics Business Overview
Table 135. Transition Therapeutics Pancreatic Beta-Cell Protection Product
Table 136. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 137. Transition Therapeutics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Beta-Cell Protection Market Share by Type: 2020 VS 2027
Figure 2. Stem Cell Based Features
Figure 3. Gene Therapies Features
Figure 4. RNA Based Therapies Features
Figure 5. Monoclonal Antibodies (MAbs) Features
Figure 6. Phytotherapy Features
Figure 7. Global Pancreatic Beta-Cell Protection Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Medical Research Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Pancreatic Beta-Cell Protection Report Years Considered
Figure 12. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pancreatic Beta-Cell Protection Market Share by Regions: 2020 VS 2027
Figure 15. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027)
Figure 16. Global Pancreatic Beta-Cell Protection Market Share by Players in 2020
Figure 17. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2020
Figure 19. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021)
Figure 20. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027)
Figure 21. North America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 23. North America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 24. North America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 25. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 29. Europe Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 30. Europe Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 31. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Region (2016-2027)
Figure 41. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 49. Latin America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 50. Latin America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 51. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 57. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 61. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 63. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 64. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 66. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 67. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 68. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 70. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 72. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 73. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 74. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed